A consumer advocacy group is asking regulators to “immediately remove” a widely used gout medication over concerns that it poses “unique, serious,” and potentially “fatal” risks to patients while not offering any health benefit.
In a petition sent to the Food and Drug Administration on Thursday, Public Citizen argued there is “overwhelming evidence that the serious cardiovascular harms of (Uloric) outweigh any purported clinical benefit,” and that a failure to remove the drug ensures “further preventable harm” to patients.
Gout, by the way, occurs when too much uric acid crystallizes and forms deposits in the joints, causing acute episodes of extreme pain.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
